| |
|
有賀 悦子 |
帝京大学医学部緩和医療学講座・教授 |
| 緩和医療学 |
| Matsuo N, Morita T, Matsuda Y, Okamoto K, Matsumoto Y, Kaneishi K, Odagiri T, Sakurai H, Katayama H, Mori I, Yamada H, Watanabe H, Yokoyama T, Yamaguchi T, Nishi T, Shirado A, Hiramoto S, Watanabe T, Kohara H, Shimoyama S, Aruga E, Baba M, Sumita K, Iwase S. Predictors of Responses to Corticosteroids for Cancer-Related Fatigue in Advanced Cancer Patients: A Multicenter, Prospective, Observational Study. J Pain Symptom Manage. 52(1): 64-72, 2016 |
| Sasahara T, Watakabe A, Aruga E, Fujimoto K, Higashi K, Hisahara K, Hori N, Ikenaga M, Izawa T, Kanai Y, Kinoshita H, Kobayakawa M, Kobayashi K, Kohara H, Namba M, Nozaki-Taguchi N, Osaka I, Saito M, Sekine R, Shinjo T, Suga A, Tokuno Y, Yamamoto R, Yomiya K, Morita T. Assessment of Reasons for Referral and Activities of Hospital Palliative Care Teams Using a Standard Format. A Multicenter 1000 Case Description. Journal of pain and symptom management. 47(3): 579-587.e6, 2013 |
| Aruga E, Tanigawa K, Aruga A, Arai H, Smith II JW, Nickoloff BJ, Nabel GJ and Chang AE; CD95-Mediated Tumor Recognition by CD4+ Effecor Cells in a Murine Mammary Model. J of Immunother, 23(29): 225-234, 2000 |
|
| |
|
天野 慎介 |
一般社団法人グループ・ネクサス・ジャパン |
| 患者支援、がん対策 |
| 天野 慎介．緩和ケアの推進に向けた課題と今後の対策．公衆衛生, 医学書院, 81巻3号, 254-259, 2017年3月 |
天野 慎介．がん患者の生活支援 患者会について．看護技術, メヂカルフレンド社, Vol.62 No.13, 2016年11月
|
| 日本緩和医療学会緩和医療ガイドライン委員会編 がん患者の呼吸器症状の緩和に関するガイドライン, 2016年版第2版, 金原出版2016年6月（Working Practitioner Group委員） |
|
| |
|
北川 雄光 |
慶應義塾大学外科学教授 |
| 外科 |
| Nagahashi M, Wakai T, Shimada Y, Ichikawa H, Kameyama H, Kobayashi T, Sakata J, Yagi R, Sato N, Kitagawa Y, Uetake H, Yoshida K, Oki E, Kudo SE, Izutsu H, Kodama K, Nakada M, Tse J, Russell M, Heyer J, Powers W, Sun R, Ring JE, Takabe K, Protopopov A, Ling Y, Okuda S, Lyle S. Genomic landscape of colorectal cancer in Japan: Clinical implications of comprehensive genomic sequencing for precision medicine. Genome Med 8(136): , 2016.12 |
| Akutsu Y, Kato, K, Igaki H, Ito Y, Nozaki I, Daiko H, Yano M, Udagawa H, Nakagawa S, Takagi M, Mizusawa J, Kitagawa Y. The Prevalence of Overall and Initial Lymph Node Metastases in Clinical T1N0 Thoracic Esophageal Cancer: From the Results of JCOG0502, a Prospective Multicenter Study. Ann Surg 246(6): 1009-1015, 2016.12 |
Yokota T, Kato K, Hamamoto Y, Tsubosa Y, Ogawa H, Ito Y, Hara H, Ura T, Kojima T, Chin K, Hironaka S, Kii T, Kojima Y, Akutsu Y, Matsushita H, Kawakami K, Mori K, Nagai Y, Asami C, Kitagawa Y. Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer. Br J Cancer 115(11): 1328-1334, 2016.11
|
|
| ○ |
|
小西 郁生 |
国立病院機構 京都医療センター・院長 |
| 産科婦人科学（婦人科腫瘍学） |
Abou-Taleb H, Yamaguchi K, Matsumura N, Murakami R, Nakai H, Higasa K, Amano Y, Abiko K, Yoshioka Y, Hamanishi J, Koshiyama M, Baba T, Yamada R, Matsuda F, Konishi I, Mandai M.
Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.
Oncotarget 7:54758-54770, 2016.
|
Yamanoi K, Matsumura N, Murphy SK, Baba T, Abiko K, Hamanishi J, Yamaguchi K, Koshiyama M, Konishi I, Mandai M.
Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer.
Oncotarget 7:47620-47636, 2016.
|
Murakami R, Matsumura N, Mandai M, Yoshihara K, Tanabe H, Nakai H, Yamanoi K, Abiko K, Yoshioka Y, Hamanishi J, Yamaguchi K, Baba T, Koshiyama M, Enomoto T, Okamoto A, Murphy SK, Mori S, Mikami Y, Minamiguchi S, Konishi I.
Establishment of a novel nistopathological classification of high-grade serous ovarian carcinoma correlated with prognostically distinct gene expression subtypes.
Am J Pathol 186:1103-1113, 2016.
|
|
| |
|
小松 浩子 |
慶應義塾看護医療学部・学部長・教授 |
| 看護学 |
| Komatsu H, Yagasaki K, Yamaguchi T. Effects of a nurse-led medication self-management programme in cancer patients: protocol for a mixed-method randomised controlled trial. BMC Nurs. 2016 Feb 8;15:9. doi: 10.1186/s12912-016-0130-1. eCollection 2016. Erratum in: BMC Nurs. 2016 Oct 24;15:61. |
Komatsu H, Watanuki S, Koyama Y, Iino K, Kurihara M, Uesugi H, Yagasaki K, Daiko H. Nurse Counseling for Physical Activity in Patients Undergoing Esophagectomy. Gastroenterol Nurs. 2016 Dec 19. doi: 10.1097/SGA.0000000000000252. [Epub ahead of print]
|
Komatsu H, Yagasaki K, Yamauchi H, Yamauchi T. Patients’ Perspectives on
Creating Personal Safety Net during Chemotherapy. Clinical Journal of
Oncology Nursing. 2016. 1;20(1):13-6.
|
|
| |
|
祖父江 友孝 |
大阪大学大学院医学系研究科・教授 |
| 専門分野 |
| Sobue T, Suzuki T, Naruke T. A case-control study for evaluating lung-cancer screening in Japan. Int J Cancer, 50: 230-7, 1992. |
| Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, Kakinuma R, Ohmatsu H, Nagai K, Nishiyama H, Matsui E, Eguchi K. Screening for lung cancer with low-dose helical computed tomography: Anti-Lung Cancer Association Project. J Clin Oncol, 20: 911-20, 2002. |
| Sobue T, Yamamoto S, Hara M, Sasazuki S, Sasaki S, Tsugane S, JPHC Study Group. Japanese Public Health Center. Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC study. Int. J. Cancer, 99: 245-251, 2002. |
|
| |
|
原 純一 |
大阪市立総合医療センター副院長 |
| 小児血液腫瘍学 |
| Development of treatment strategies for advanced neuroblastoma. Hara J. Int J Clin Oncol. 2012 Jun;17(3):196-203. |
Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors. Hara J, Osugi Y, Ohta H, Matsuda Y, Nakanishi K, Takai K, Fujisaki H, Tokimasa S, Fukuzawa M, Okada A, Okada S.Bone Marrow Transplant. 1998 Jul;22(1):7-12.
|
Comparison of T cell receptor alpha, beta, and gamma gene rearrangement and expression in T cell acute lymphoblastic leukemia. Hara J, Benedict SH, Champagne E, Mak TW, Minden M, Gelfand EW.
J Clin Invest. 1988 Apr;81(4):989-96.
|
|
| |
|
伏見 清秀 |
東京医科歯科大学医療政策情報学分野・教授 |
| 医療政策学・医療官理学 |
Inoue, T., Fushimi, K. Stroke Care Units Versus General Medical Wards for Acute Management of Stroke in Japan. Stroke. 2013; 44(11): 3142-7. doi: 10.1161/STROKEAHA.113.001684.
|
| Ohnuma, T., Daisuke Shinjo, D., Fushimi, K. Hospital mortality of patients aged 80 and older after surgical repair for type A acute aortic dissection in Japan. Medicine (Baltimore). 201608; 95(31): e4408〜e4408. |
| 伏見清秀. 院内ビッグデータ分析による病院機能高度化. じほう, 2016.06 |
|
| |
|
中釜 斉 |
国立がん研究センター 理事長・総長 |
| 専門分野 |
| Kanemoto K, Fukuta K, Kawai N, Tozawa K, Ochiai M, Okamoto K, Ohnami S, Sakamoto H, Yoshida T, Kanai Y, Katoh M, Yasui T, Kohri K, Kakizoe T, Nakagama H. Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype. PLoS One, 11(11):e0167374, 2016. |
Yachida S, Wood LD, Suzuki M, Takai E, Totoki Y, Kato M, Luchini C, Arai Y, Nakamura H, Hama N, Elzawahry A, Hosoda F, Shirota T, Morimoto N, Hori K, Funazaki J, Tanaka H, Morizane C, Okusaka T, Nara S, Shimada K, Hiraoka N, Taniguchi H, Higuchi R, Oshima M, Okano K, Hirono S, Mizuma M, Arihiro K, Yamamoto M, Unno M, Yamaue H, Weiss MJ, Wolfgang CL, Furukawa T, Nakagama H, Vogelstein B, Kiyono T, Hruban RH, Shibata T. Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma. Cancer Cell, 29(2):229-40, 2016
|
| Ishiguro T, Sato A, Ohata H, Ikarashi Y, Takahashi RU, Ochiya T, Yoshida M, Tsuda H, Onda T, Kato T, Kasamatsu T, Enomoto T, Tanaka K, Nakagama H, Okamoto K. Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity. Cancer Res, 76(1):150-160, 2016 |
|
